ARMILLOTTA, MATTEO
 Distribuzione geografica
Continente #
AS - Asia 3.662
EU - Europa 1.671
NA - Nord America 1.663
SA - Sud America 193
AF - Africa 69
OC - Oceania 1
Totale 7.259
Nazione #
US - Stati Uniti d'America 1.582
VN - Vietnam 1.306
IT - Italia 897
SG - Singapore 751
CN - Cina 699
HK - Hong Kong 254
BD - Bangladesh 189
NL - Olanda 165
BR - Brasile 142
IN - India 137
KR - Corea 132
DE - Germania 121
GB - Regno Unito 100
FI - Finlandia 80
FR - Francia 70
JP - Giappone 46
CA - Canada 41
RU - Federazione Russa 30
AR - Argentina 27
ES - Italia 27
PH - Filippine 26
MX - Messico 24
PL - Polonia 24
AT - Austria 23
CH - Svizzera 21
IE - Irlanda 20
TH - Thailandia 19
ID - Indonesia 17
TR - Turchia 16
BG - Bulgaria 15
CI - Costa d'Avorio 13
EG - Egitto 12
TW - Taiwan 11
ZA - Sudafrica 11
HU - Ungheria 10
IQ - Iraq 10
SA - Arabia Saudita 10
SE - Svezia 9
BE - Belgio 8
JO - Giordania 8
CO - Colombia 6
EC - Ecuador 6
IR - Iran 6
CL - Cile 5
GR - Grecia 5
NG - Nigeria 5
PT - Portogallo 5
RO - Romania 5
SC - Seychelles 5
TG - Togo 5
UA - Ucraina 5
DK - Danimarca 4
HN - Honduras 4
MY - Malesia 4
PK - Pakistan 4
UZ - Uzbekistan 4
DZ - Algeria 3
GH - Ghana 3
GT - Guatemala 3
HR - Croazia 3
IL - Israele 3
JM - Giamaica 3
KE - Kenya 3
NP - Nepal 3
PY - Paraguay 3
RS - Serbia 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
AZ - Azerbaigian 2
BF - Burkina Faso 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
LT - Lituania 2
LU - Lussemburgo 2
LV - Lettonia 2
MD - Moldavia 2
PE - Perù 2
SN - Senegal 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
LK - Sri Lanka 1
LY - Libia 1
MA - Marocco 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
SV - El Salvador 1
TM - Turkmenistan 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
VE - Venezuela 1
Totale 7.259
Città #
Singapore 535
Ho Chi Minh City 384
Hanoi 335
Ashburn 293
Hefei 267
Hong Kong 234
Bologna 184
San Jose 171
Seoul 117
Santa Clara 103
Milan 87
Council Bluffs 80
Rome 74
Los Angeles 73
The Dalles 69
Beijing 66
Da Nang 66
Haiphong 61
Boardman 57
Dallas 57
Chandler 48
Helsinki 48
New York 47
Enfield 44
Tokyo 40
Frankfurt am Main 37
Munich 31
São Paulo 29
Buffalo 27
Hyderabad 27
Lauterbourg 26
Delhi 25
Bengaluru 23
Bern 21
Verona 21
Dublin 20
Turku 20
Hải Dương 19
Nuremberg 19
Thái Nguyên 19
Houston 17
Mumbai 17
Chicago 16
Warsaw 16
Biên Hòa 15
Phoenix 15
Redondo Beach 15
Turin 15
Vienna 15
Amsterdam 14
Mexico City 14
Modena 14
Sofia 14
Abidjan 13
Bến Tre 13
Can Tho 13
London 13
Castel Maggiore 12
Montreal 12
Naples 12
Philadelphia 12
Quận Bình Thạnh 12
Falkenstein 11
Forlì 11
Ha Long 11
Orem 11
Seattle 11
Shanghai 11
Vũng Tàu 11
Bắc Ninh 10
Lappeenranta 10
San Francisco 10
Súria 10
Toronto 10
Tân Tiến 10
Budapest 9
Charlotte 9
Vicenza 9
Johannesburg 8
Ninh Bình 8
Palermo 8
Rimini 8
Amman 7
Bari 7
Copparo 7
Dhaka 7
Düsseldorf 7
Jakarta 7
Louisville 7
Padova 7
Thái Bình 7
Acalanes Ridge 6
Baghdad 6
Chennai 6
City of London 6
Figino 6
Hai Bà Trưng 6
Huế 6
Madrid 6
Malden 6
Totale 4.526
Nome #
Impact of admission hyperglycemia on short and long-term prognosis in acute myocardial infarction: MINOCA versus MIOCA 439
Sex-Related Disparities in Cardiac Masses: Clinical Features and Outcomes 267
Prognostic Relevance of Type 4a Myocardial Infarction and Periprocedural Myocardial Injury in Patients With Non–ST-Segment–Elevation Myocardial Infarction 256
Classificazione, caratteristiche cliniche e strategie diagnostiche delle masse cardiache 233
Cardiac Magnetic Resonance to Predict Cardiac Mass Malignancy: The CMR Mass Score 222
Impact of SGLT2-inhibitors on acute kidney injury in diabetic patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) 220
Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry 217
Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure 214
Ematoma subepicardico: una rara complicanza dell’angioplastica coronarica percutanea 211
Performance of Prognostic Scoring Systems in MINOCA: A Comparison among GRACE, TIMI, HEART, and ACEF Scores 199
Clinical impact of multimodality assessment of myocardial viability 194
Development and Validation of a Diagnostic Echocardiographic Mass Score in the Approach to Cardiac Masses 188
Multimodality Imaging in the Diagnostic Work-Up of Patients With Cardiac Masses 185
Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA 176
Evolution of cardiovascular risk factors and the risk for cardiovascular events in a Caucasian population with polycystic ovary syndrom 167
Periprocedural myocardial injury and infarction after myocardial revascularization: incidence, clinical features and prognosis 164
Pathological findings at invasive assessment in MINOCA: a systematic review and meta-analysis 162
Impact of Newly Diagnosed Cancer on Bleeding Events in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants 158
The Role of Non-Invasive Multimodality Imaging in Chronic Coronary Syndrome: Anatomical and Functional Pathways 155
Prognostic Role of Early Cardiac Magnetic Resonance in Myocardial Infarction With Nonobstructive Coronary Arteries 150
Reply to SGLT-2 inhibitors: Post-infarction interventional effects 150
SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI) 145
Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry 145
Sex- and age-related differences in outcomes of patients with acute myocardial infarction: MINOCA vs. MIOCA 144
Noninvasive Assessment in Takotsubo Syndrome: A Diagnostic Challenge 135
In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study 135
Multimodality Non-Invasive Imaging Approach in Acute Coronary Syndrome: Diagnostic and Prognostic Assessment 125
Echocardiographic Markers in the Diagnosis of Cardiac Masses 123
The never-ending challenge of anti-inflammatory therapy after acute myocardial infarction 121
Characteristics of patients with recurrent acute myocardial infarction after MINOCA 119
CTA-Derived Pericoronary Fat Attenuation Index Predicts Allograft Rejection and Cardiovascular Events in Heart Transplant Recipients 112
A textured clinical mosaic involving autoimmune calcific constrictive pericarditis: a case report 109
Non-invasive imaging assessment in angina with non-obstructive coronary arteries (ANOCA) 106
Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry 104
Predictive value of Killip classification in MINOCA patients 103
The Spectrum of ECG Abnormalities in a Large Cohort of Cardiac Masses 102
Identification of Clinical Phenotypes in Type 2 Myocardial Infarction: Insights Into Characteristics, Prognosis, and Management Strategies 102
Cardiac magnetic resonance imaging in myocardial infarction with non-obstructive coronary arteries (MINOCA): current and evolving perspectives 101
MINOCA and inflammation: Another piece of the puzzle 100
Beyond Coronary Calcium: A New Era in Cardiovascular Risk Assessment 100
Impact of glucometabolic status on type 4a myocardial infarction in patients with non–ST-segment elevation myocardial infarction: the role of stress hyperglycemia ratio 97
Hallmarks of Left Ventricular Apical Cardiac Mass in a Young Patient 95
Gender and Sex-related differences in Type 2 Myocardial Infarction: the undervalued side of a neglected disease 86
Coronary microvascular dysfunction beyond the spectrum of chronic coronary syndromes 84
Unifying Diagnosis Explaining Multiorgan Clinical Manifestations: The Unique Case of Antiphospholipid Syndrome Leading to MINOCA 69
Authors' reply to: 'preventing atrial fibrillation with SGLT2 inhibitors: time, sex, and substrate' by Karakasis et al 68
Prevention of atrial fibrillation with SGLT2 inhibitors across the spectrum of cardiovascular disorders: a meta-analysis of randomized controlled trials 67
Cardiac troponin elevation after coronary artery bypass graft: improving risk stratification 62
Bridging the gap: a comprehensive toolkit for assessment of coronary microcirculation in clinical practice 56
Periprocedural myocardial infarction after coronary artery bypass grafting: defining what matters 44
Editorial commentary: Beyond coronary anatomy in acute myocardial infarction: Could stress hyperglycemia ratio be a new prognostic index and therapeutic target? 38
Cardiac magnetic resonance-derived left atrioventricular coupling index predicts outcome in reduced ejection fraction 24
Impaired left atrial strain as a predictor of bradyarrhythmias and clinical outcomes following TAVI 21
Periprocedural Myocardial Infarction: Do We Need an Updated Definition? 21
Impact of P2Y12 inhibitor pretreatment on periprocedural (type 4a) myocardial infarction and bleeding in NSTEMI 13
Colchicine in stable coronary artery disease: slowing plaque progression assessed by coronary computed tomography angiography 7
CardioRadNet: Cardiac mass diagnosis through integrated segmentation and radiomic analysis 3
Totale 7.413
Categoria #
all - tutte 18.075
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.075


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/202266 4 0 3 6 5 3 0 4 0 7 14 20
2022/2023284 6 17 2 16 18 15 13 13 22 11 109 42
2023/2024294 11 17 22 14 16 40 10 41 18 60 23 22
2024/20251.507 67 66 65 61 141 67 78 101 74 190 199 398
2025/20265.251 625 398 410 330 401 184 920 125 815 297 380 366
Totale 7.413